Search result for RNA
The FDA has approved Moderna and Pfizer's revised COVID-19 booster shot for use in children as young as 5.
Wednesday, the Food and Drug Administration approved Moderna and Pfizer's modified COVID-19 booster doses for children as young as 5 years old, out of worry for increasing exposure now that youngsters are back in school and participating in other activities.
Peter Marks, the head va...
After a new agreement, the NHS will have access to transformative mRNA technology
Following the Government's agreement with Moderna to establish a cutting-edge manufacturing facility in the UK, NHS patients will now have access to the most recent technological developments, therapies, and vaccinations, including "transformative" mRNA technology.
The new...
A husband-and-wife team of scientists pleaded guilty to illegally importing potentially toxic lab chemicals and sending confidential mRNA vaccine research to China
Chenyan Wu and Lianchun Chen, a married couple who worked as research scientists for a major American pharmaceutical company, pleaded guilty today in federal court to criminal charges stemming from their efforts to obtain confidential mRNA research from that company to advance their husband's...
A new law tries to address the mental health issue among healthcare workers, but there are still obstacles to care
In two years, a lot can happen. It's difficult to imagine life before we had to deal with a global pandemic that affected everything, both literally and emotionally.
That transformation came quickly for our family. Dr Lorna Breen, an excellent NYC emergency room physician who worked...
Just weeks after unveiling its first COVID-19 vaccine prototype, the WHO's mRNA technology is moving to Asia and Europe
So far, the initiative has generated a prototype COVID-19 vaccine that is comparable to Moderna's but not identical. It's based on the same publicly accessible sequence, but due to Moderna's unwillingness to help (beyond pledging not to pursue its patents during the epidemic), W...
Global RNA Based Therapeutics Market was Valued at US$ 4721.82 Mn in 2020 Growing at a CAGR of 16.87% over the forecast period
Antisense Oligonucleotides (ASO’s) to Hold Largest Market Share in 2020
According to the Absolute Markets Insights report, antisense oligonucleotides accounted for the largest market share in 2020. Antisense oligonucleotides have gained a significant importance s...
Global mRNA Vaccines Market Research Report [2021-2029] - A Report by Absolute Markets Insights
According to a report published by AMI, the global mRNA vaccines market is anticipate to grow at a CAGR of 19.76% during the forecast period. The rapid advancement in medical technology that promotes the development of mRNA vaccines, coupled with the growth of infectious diseases globally is a ma...
Singapore Finds Moderna to be the Best Vaccine
According to research in Singapore, Moderna and Pfizer vaccines for the coronavirus have been observed to be more successful in preventing deaths than the Sinopharm and Sinovac.
The island saw 802 deaths in 2021 due to Covid-19. 555 of these individuals had not been fully vaccinated whe...
Moderna Vaccine to be Manufactured in Australia
Australia is planning to produce the Moderna vaccine for the Covid-19. The country plans on putting together 100 million shots per year.
An agreement has been signed between Moderna, Australia’s federal government, and the government of Victoria to set up a facility in Victoria by...
CureVac to begin clinical trials for second-generation COVID-19 vaccine
German biotechnology company CureVac said on November 18 that clinical trials for its second-generation COVID-19 vaccine will begin in the next few months.
Highlights
- CureVac to begin clinical trials of its second-generation COVID-19 vaccine
Japan receives around 180,000 contaminated shots of Moderna vaccine, halts immunization
HIGHLIGHTS
- Japan receives contaminated vaccine shots of Moderna vaccine
- 180,000 vaccine sots are assumed to be contaminated
The Japanese health ministry had given Emergency use approval to Moderna in May this y...
SOUTH KOREAN PM SAYS COUNTRY TO SECURE MORE mRNA VACCINES TO USE THEM AS A BOOSTER SHOT
Highlights
• Kim said "The government plans to first secure vaccine supply, mostly mRNA ones, enough to vaccinate the entire public with at least one shot next year.”
According to a statement by the Prime Minister of South Korea, Kim Boo-kyum is planning to sec...
JAPAN’S STATE-RUN CENTERS TO GIVE COVID-19 VACCINES UNDER AGES 18 -64
Highlights –
- Japan’s state-run centers to give COVID-19 vaccines under ages 18 - 64.
- The centers in Tokyo and Osaka were set up last month by the Defense Ministry.
- The ministry last week expanded the scope to accept people from ...
JAL BEGAN COVID-19 VACCINATION FOR ITS EMPLOYEES
Highlights –
- JAL began COVID-19 vaccination for its employees.
- The airlines decided to begin administering shots at Tokyo's Haneda airport.
- JAL aims to inoculate about 36,000 group employees.
- JR East, Itochu Corp., univ...
JAPAN GOVT. APPROVES PFIZER’S COVID-19 VACCINES FOR 12-15 YEAR OLD
Highlights –
- Japan govt. approves Pfizer’s COVID-19 vaccines for 12-15 year old.
- The age group will be able to receive shots free of charge.
- Only around 6% of the country's population of 126 million has been given at least o...
JAPAN TO DISCUSS APPROVAL FOR MODERNA, ASTRAZENECA’S COVID-19 VACCINE
Highlights –
- Japan to discuss approval for Moderna, AstraZeneca COVID-19 vaccine.
- The formal approval could be expected to come on Friday.
- The same vaccines are used overseas for people aged 18 or older.
- Prime Minister Yosh...
JAPAN GOVT. TO SET ASIDE $4.7 BILLION FOR FY 2021 IN RESERVE FUNDS
Highlights –
- Japan govt. to set aside $4.7 billion for FY 2021 in reserve funds.
- The funds will be earmarked to purchase more COVID-19 vaccines.
- Pfizer is expected to supply 50 million doses from July through September.
- Jap...
NEW OMNE POSSIBILE CAN HARNESS TRANSFORMATIVE POWER OF XNA
HIGHLIGHTS
- Omne Possibile has been launched to harness the power of XNA in healthcare.
- Through Omne Possibile, the power of XNA can be used in IT and smart materials.
- A pioneering, global technological leader in XNA, Omne Possibile creates ...
CHINA DEVELOPED mRNA VACCINE LIKELY TO START TRIALS NEXT MONTH
Highlights –
- China developed mRNA vaccine likely to start trials next month.
- The vaccine candidate ARCoV is said to be the furthest along the clinical trial process at present.
- The vaccine may get overseas approval to conduct Phase II...
US FDA GIVES CLEARANCE TO MODERNA TO SPEED UP OUTPUT OF ITS COVID-19 VACCINE
Highlights
• The US Food and Drug Administration (FDA) on Friday granted clearance to Moderna to speed up output of its coronavirus vaccine by allowing it fill a single with nearly 15 doses
• Moderna said the vaccine developed by it now can be supplied in vials conta...